Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) Cash from Financing Activities (2023 - 2026)

Updated

Odyssey Therapeutics (ODTX) reported Cash from Financing Activities of -$3.18 million for Q3 2026, compared with $90.78 million a year earlier.

Analysis

Odyssey Therapeutics (ODTX) Cash from Financing Activities (2023 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Odyssey Therapeutics' Cash from Financing Activities came in at $295.41 million, up 36.4% year-over-year; for FY2025, it was $215.65 million, up 699.3% from FY2024.

  • Cash from Financing Activities has a three-year compound annual growth rate of 5.7% (FY2022 to FY2025).
  • By year, Cash from Financing Activities came in at $26.98 million in FY2024 (-70.7%), $92.08 million in FY2023 (-49.6%) and $182.72 million in FY2022.
  • The Q3 2026 figure ranks as the lowest quarterly Cash from Financing Activities in data going back to Q4 2023.
  • Year over year, Cash from Financing Activities gained in two of the last four quarters, with growth averaging 45.6%.
  • Per Business Quant data, the three quarters before Q3 2026 came in at $292.16 million (Q2 2026), $484,000 (Q1 2026) and $5.94 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -7.22 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -8.53 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 6.82 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -2.43 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 6.63 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -4.39 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -1.53 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -2.51 Bn
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn - -3.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -3.18 Mn
Jun 30, 2026 292.16 Mn
Mar 31, 2026 484,000.00
Dec 31, 2025 5.94 Mn
Sep 30, 2025 90.78 Mn
Jun 30, 2025 118.72 Mn
Mar 31, 2025 200,000.00
Dec 31, 2024 6.82 Mn
Dec 31, 2023 96.60 Mn
API Access

Odyssey Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ODTX&period=max&api_key=YOUR_API_KEY